Difference between revisions of "SOCR News UMich CCC HnN Retreat 2018"

From SOCR
Jump to: navigation, search
(Created page with "== SOCR News & Events: Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics == ==Logistics== * '''Event''': 2018 [https://www.mcancer.org/head-an...")
 
(Outline)
 
(3 intermediate revisions by the same user not shown)
Line 2: Line 2:
  
 
==Logistics==
 
==Logistics==
 +
[[Image:SOCR_Logo_April_2018.png|150px|thumbnail|right| [http://socr.umich.edu SOCR Resource] ]]
 
* '''Event''': 2018 [https://www.mcancer.org/head-and-neck-cancer Head and Neck Oncology Program Retreat]
 
* '''Event''': 2018 [https://www.mcancer.org/head-and-neck-cancer Head and Neck Oncology Program Retreat]
 
* '''Place/Time''': Friday May 11, 2018, 7:30AM-4:00PM, University of Michigan, Pierpont Commons (East Room), 2101 Bonisteel Blvd, Ann Arbor, MI 48109.
 
* '''Place/Time''': Friday May 11, 2018, 7:30AM-4:00PM, University of Michigan, Pierpont Commons (East Room), 2101 Bonisteel Blvd, Ann Arbor, MI 48109.
 
* '''Presenter''': [http://www.umich.edu/~dinov/ Ivo D Dinov]
 
* '''Presenter''': [http://www.umich.edu/~dinov/ Ivo D Dinov]
 +
 +
== Program==
 +
<center>
 +
{| class="wikitable"
 +
|-
 +
! Time
 +
! Title
 +
! Presenter
 +
|-
 +
| 7:30-8:00  || Breakfast  ||
 +
|-
 +
| 8:00-8:15  ||History of HNOP and Future Plans  || Tom Carey/ Mark Prince
 +
|-
 +
| 8:15-8:30  || Multi-parametric MRI for assessment of Progression UMCC 2013.062 Phase 2 randomized trial in Poor Prognosis HNSCC || Michele Mierswa
 +
|-
 +
| 8:30-8:45  ||Imaging Findings in UMCC 2013.062  ||  Yue Cao
 +
|-
 +
| 8:45-9:00  || Effects of definitive ChemoRT on neck function || David Lipps/Michele Mierswa/Paul Swiecicki/Sean Smith
 +
|-
 +
| 9:00-9:15  || Individualized survival Prediction for Patients with OPSCC +/- HPV || Peter Hawkins
 +
|-
 +
| 9:15-9:30  ||Therapeutic Targeting of adenoid cystic Carcinoma stem cells  ||  Jacques Nor
 +
|-
 +
| 9:30-10:45 || Lipidomic profiling identifies phospholipase A2 as a novel therapy || Mark Cohen
 +
|-
 +
| 10:00-10:15  ||Coffee Break ||
 +
|-
 +
| 10:15-10:30  ||Molecular profiling of sinonasal Papillomas: Mechanisms of  oncogenesis and malignant progression ||  Aaron Udager                 
 +
|-
 +
| 10:35-10:45  ||Identification of HPV-human fusion Transcripts in HNSCC cell lines and tumors || Lisa Pinatti                               
 +
|-
 +
| 10:30-10:45  ||Expressed HNSCC mutations by HPV status in a Michigan Cohort || TingTing Qin/Maureen Sartor
 +
|-
 +
| 10:45-11:00  ||5-hydroxymethylation captures the heterogeneity in keratinization || Siyu Liu/Maureen Sartor
 +
|-
 +
| 11:00-11:15  ||Using small molecule profiling to identify effective combination  Therapies in HNSCC || Nicole Michmerhuizen
 +
|-
 +
| 11:15-11:30  ||Update on the Low Risk OPSCC Surgical Trial  ||  Matt Spector
 +
|-
 +
| 11:30-11:45  ||Predicting wound healing in salvage surgery: SPY, MRI and TSH  || Matt Spector
 +
|-
 +
| 11:45-12:00  ||Update on the MiOtoSeq Study  ||  Collin Brummel/Chad Brenner
 +
|-
 +
| 11:40-11:50  ||MiOto genetics and Clinical analysis  ||  Keith Casper/Nick
 +
|-
 +
| 11:50-12:00  ||Investigating mechanisms of PD-L1 regulation in UMSCC cell lines || Jackie Mann
 +
|-
 +
| 12:00 -1:00 || LUNCH  ||  All
 +
|-
 +
| 1:00-1:15 || TBA  ||  Nisha D’Silva
 +
|-
 +
| 1:15-1:30 || Mucoepidermoid Cancer RNASeq and ctDNA analysis  ||  Chad Brenner
 +
|-
 +
| 1:30-1:45  ||Loss of E2 promotes cisplatin resistance in HPV16 Positive HNSCC || Josh Smith
 +
|-
 +
| 1:45-2:00  || Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics || Ivo Dinov
 +
|-
 +
| 2:00-2:15  ||Genetic analysis of HPV+ OPSCC  ||  Chad Brenner
 +
|-
 +
| 2:15-2:30  ||Coffee Break ||
 +
|-
 +
| 2:30-3:15  ||Head and Neck/Endocrine Clinical Trials Update  Inhibition in HNSCC ||  Frank Worden Shannon Musser
 +
|-
 +
| 3:15-3:30 || Physical and Cognitive Function, Symptom Distress and Quality of Life in Head and Neck Cancer || Moira Visovatti
 +
|-
 +
| 3:30-3:45  ||Novel Therapeutics and Emerging Biomarkers in Head & Neck Cancers || Paul Sweicicki
 +
|-
 +
| 3:00-4:00  ||Overview and Discussion of Future translational projects  ||  All
 +
|}
 +
</center>
  
 
==Outline==
 
==Outline==
[[Image:SOCR_Logo_April_2018.png|150px|thumbnail|right| [http://socr.umich.edu SOCR Resource] ]]
+
We developed computational statistics and machine learning methods for H&N Cancer analytics. Three applications of the new methods on the H&N cancer dataset (n~350) include: (1) predicting univariate clinical outcomes (e.g., cancer staging), (2) processing unstructured clinical notes and medication data, and, (3) generating machine-learning models of association.
We explore computational statistics and machine learning methods, specifically for H&N Cancer analytics. Specifically, we developed new methods and tested them on the H&N cancer dataset (n~350). Specifically, we will demonstrate the infrastructure for predicting univariate clinical outcomes (e.g., cancer staging), processing unstructured clinical notes and medication data, and generating machine-learning models of association.
 
  
 
==Slidedeck==
 
==Slidedeck==
[ Dr. Dinov's slides are available here].
+
[http://socr.umich.edu/docs/uploads/2018/Dinov_Predictive_Cancer_HnN_Analytics_2018_Retreat.pdf Dr. Dinov's slides are available here].
 +
 
  
 
==References==
 
==References==

Latest revision as of 09:12, 18 May 2018

SOCR News & Events: Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics

Logistics

Program

Time Title Presenter
7:30-8:00 Breakfast
8:00-8:15 History of HNOP and Future Plans Tom Carey/ Mark Prince
8:15-8:30 Multi-parametric MRI for assessment of Progression UMCC 2013.062 Phase 2 randomized trial in Poor Prognosis HNSCC Michele Mierswa
8:30-8:45 Imaging Findings in UMCC 2013.062 Yue Cao
8:45-9:00 Effects of definitive ChemoRT on neck function David Lipps/Michele Mierswa/Paul Swiecicki/Sean Smith
9:00-9:15 Individualized survival Prediction for Patients with OPSCC +/- HPV Peter Hawkins
9:15-9:30 Therapeutic Targeting of adenoid cystic Carcinoma stem cells Jacques Nor
9:30-10:45 Lipidomic profiling identifies phospholipase A2 as a novel therapy Mark Cohen
10:00-10:15 Coffee Break
10:15-10:30 Molecular profiling of sinonasal Papillomas: Mechanisms of oncogenesis and malignant progression Aaron Udager
10:35-10:45 Identification of HPV-human fusion Transcripts in HNSCC cell lines and tumors Lisa Pinatti
10:30-10:45 Expressed HNSCC mutations by HPV status in a Michigan Cohort TingTing Qin/Maureen Sartor
10:45-11:00 5-hydroxymethylation captures the heterogeneity in keratinization Siyu Liu/Maureen Sartor
11:00-11:15 Using small molecule profiling to identify effective combination Therapies in HNSCC Nicole Michmerhuizen
11:15-11:30 Update on the Low Risk OPSCC Surgical Trial Matt Spector
11:30-11:45 Predicting wound healing in salvage surgery: SPY, MRI and TSH Matt Spector
11:45-12:00 Update on the MiOtoSeq Study Collin Brummel/Chad Brenner
11:40-11:50 MiOto genetics and Clinical analysis Keith Casper/Nick
11:50-12:00 Investigating mechanisms of PD-L1 regulation in UMSCC cell lines Jackie Mann
12:00 -1:00 LUNCH All
1:00-1:15 TBA Nisha D’Silva
1:15-1:30 Mucoepidermoid Cancer RNASeq and ctDNA analysis Chad Brenner
1:30-1:45 Loss of E2 promotes cisplatin resistance in HPV16 Positive HNSCC Josh Smith
1:45-2:00 Exploratory, Confirmatory, & Predictive Big Cancer Data Analytics Ivo Dinov
2:00-2:15 Genetic analysis of HPV+ OPSCC Chad Brenner
2:15-2:30 Coffee Break
2:30-3:15 Head and Neck/Endocrine Clinical Trials Update Inhibition in HNSCC Frank Worden Shannon Musser
3:15-3:30 Physical and Cognitive Function, Symptom Distress and Quality of Life in Head and Neck Cancer Moira Visovatti
3:30-3:45 Novel Therapeutics and Emerging Biomarkers in Head & Neck Cancers Paul Sweicicki
3:00-4:00 Overview and Discussion of Future translational projects All

Outline

We developed computational statistics and machine learning methods for H&N Cancer analytics. Three applications of the new methods on the H&N cancer dataset (n~350) include: (1) predicting univariate clinical outcomes (e.g., cancer staging), (2) processing unstructured clinical notes and medication data, and, (3) generating machine-learning models of association.

Slidedeck

Dr. Dinov's slides are available here.


References





Translate this page:

(default)
Uk flag.gif

Deutsch
De flag.gif

Español
Es flag.gif

Français
Fr flag.gif

Italiano
It flag.gif

Português
Pt flag.gif

日本語
Jp flag.gif

България
Bg flag.gif

الامارات العربية المتحدة
Ae flag.gif

Suomi
Fi flag.gif

इस भाषा में
In flag.gif

Norge
No flag.png

한국어
Kr flag.gif

中文
Cn flag.gif

繁体中文
Cn flag.gif

Русский
Ru flag.gif

Nederlands
Nl flag.gif

Ελληνικά
Gr flag.gif

Hrvatska
Hr flag.gif

Česká republika
Cz flag.gif

Danmark
Dk flag.gif

Polska
Pl flag.png

România
Ro flag.png

Sverige
Se flag.gif